$EIKN SEC Filings

Filed On	Filing
26 Oct 2026	8-K: Regulation FD Disclosure; Other Events Eikon Therapeutics Presents Updated EIK1001 Data from TeLuRide-005 at the European Society for Medical Oncology Congress
23 Oct 2026	8-K: Regulation FD Disclosure; Other Events Eikon Therapeutics Presents Data from PARP1-Selective and WRN Helicase Programs at the European Society for Medical Oncology Congress
07 Oct 2026	SCHEDULE 13G/A
02 Oct 2026	SCHEDULE 13G/A
08 Sep 2026	Form 4: Column Group Iv GP, Lp, 10% owner and 7 others Bought 89,200 shares ($1.03M)
14 Aug 2026	8-K: Regulation FD Disclosure
13 Aug 2026	10-Q
13 Aug 2026	8-K: Results of Operations and Financial Condition
06 Aug 2026	SCHEDULE 13G/A
03 Aug 2026	8-K: Departure/Election of Directors or Officers; Compensation
15 Jun 2026	Form 3: Francisco Ma. Fatima, Director
10 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation
01 Jun 2026	8-K: Regulation FD Disclosure; Other Events
15 May 2026	SCHEDULE 13G
13 May 2026	SCHEDULE 13G
11 May 2026	10-Q
11 May 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
06 May 2026	SCHEDULE 13G
29 Apr 2026	SCHEDULE 13G
30 Mar 2026	10-K

Comments